Hjem › Multipel sklerose
Multipel sklerose kliniske forsøg rekrutterer i USA
131 studier for Multipel sklerose rekrutterer deltagere på steder over hele USA.
Byer med flest studier
- New York City, NY17 studier
- Chicago, IL15 studier
- Boston, MA14 studier
- Washington, DC13 studier
- Cleveland, OH9 studier
- St. Louis, MO8 studier
- Birmingham, AL8 studier
- Kansas City, KS8 studier
- San Francisco, CA8 studier
- Columbus, OH7 studier
- Aurora, CO7 studier
- Baltimore, MD7 studier
- Farmington Hills, MI6 studier
- Seattle, WA6 studier
- Dallas, TX6 studier
- Houston, TX6 studier
- Milwaukee, WI6 studier
- Tampa, FL5 studier
- San Diego, CA5 studier
- Atlanta, GA5 studier
- Austin, TX5 studier
- Scottsdale, AZ4 studier
- Brockton, MA4 studier
- Knoxville, TN4 studier
- Naples, FL4 studier
- Durham, NC4 studier
- New Haven, CT4 studier
- Ann Arbor, MI4 studier
- Miami, FL4 studier
- Orlando, FL4 studier
- Champaign, IL4 studier
- Clifton, NJ3 studier
- Rochester, MN3 studier
- Philadelphia, PA3 studier
- Kirkland, WA3 studier
- Cincinnati, OH3 studier
- Buffalo, NY3 studier
- Raleigh, NC3 studier
- Omaha, NE3 studier
- Honolulu, HI3 studier
Efter delstat
- Alabama8 studier
- Arizona6 studier
- Californien24 studier
- Colorado11 studier
- Connecticut6 studier
- District of Columbia4 studier
- Florida14 studier
- Georgia7 studier
- Hawaii3 studier
- Illinois19 studier
- Kansas9 studier
- Kentucky3 studier
- Maryland17 studier
- Massachusetts18 studier
- Michigan10 studier
- Minnesota4 studier
- Missouri8 studier
- Nebraska3 studier
- New Jersey11 studier
- New York19 studier
- North Carolina8 studier
- Ohio14 studier
- Oklahoma3 studier
- Pennsylvania7 studier
- Tennessee6 studier
- Texas17 studier
- Utah3 studier
- Virginia3 studier
- Washington10 studier
- Wisconsin7 studier
Nyligt opdaterede studier
Officiel studietekst (engelsk)
Targeting Residual Activity By Precision, Biomarker-Guided Combination Therapies of Multiple Sclerosis (TRAP-MS)
RekruttererFase 1/2
Alder 18 til 120 · Alle køn · Opdateret 2. okt. 2026 · NCT03109288A Study of the MIND Diet for Persons With Multiple Sclerosis
Rekrutterer
Alder 18 til 70 · Alle køn · Opdateret 2. okt. 2026 · NCT06992115Comprehensive Multimodal Analysis of Neuroimmunological Diseases of the Central Nervous System
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
1 Month – 99 Years · Alle køn · Opdateret 2. okt. 2026 · NCT00794352A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity
RekruttererFase 2
Alder 18 til 70 · Alle køn · Opdateret 1. okt. 2026 · NCT06782490A Study of Ocrelizumab Administered Subcutaneously in Participants With Multiple Sclerosis Who Switch From an Approved Anti-CD20 Therapy
RekruttererFase 4
Alder 18 til 65 · Alle køn · Opdateret 30. sep. 2026 · NCT07609719Vancomycin Study in Multiple Sclerosis (MS)
RekruttererFase 1
Alder 18 til 50 · Alle køn · Opdateret 28. sep. 2026 · NCT05539729A Phase 2a Study of SUN-627 in Participants With Non-Active Secondary Progressive and Primary Progressive Multiple Sclerosis (SPMS/PPMS)
RekruttererFase 2
Alder 18 til 70 · Alle køn · Opdateret 25. sep. 2026 · NCT07840326Understanding the Impact of Meal Timing on Neurological Health in Adults With Multiple Sclerosis
Rekrutterer
Alder 18 til 64 · Alle køn · Opdateret 25. sep. 2026 · NCT07475377Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 23. sep. 2026 · NCT03816345A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 23. sep. 2026 · NCT06433752Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis
RekruttererFase 1/2
Alder 18 til 65 · Alle køn · Opdateret 21. sep. 2026 · NCT07477639A Study Evaluating the Effect of BRIUMVI® (Ublituximab) on Pregnancy and Infant Outcomes in Participants With Multiple Sclerosis (MS)
RekruttererObservationsstudie
Alder 15 til 50 · Kvinder · Opdateret 21. sep. 2026 · NCT06433765Delivery of a Culturally Tailored Exercise Training Intervention for Hispanics With Multiple Sclerosis
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 17. sep. 2026 · NCT07606742Effect of Corticosteroids on Inflammation at the Edge of Acute Multiple Sclerosis Plaques
RekruttererFase 2
Alder 18 til 120 · Alle køn · Opdateret 16. sep. 2026 · NCT02784210Clinical Applications of Advanced Ophthalmic Imaging
RekruttererFrivillige med god helbredstilstand velkomne
Alder 18 til 99 · Alle køn · Opdateret 16. sep. 2026 · NCT03135327Magnetic Resonance Imaging (MRI) to Evaluate Activity of Multiple Sclerosis (MS)
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 18 til 120 · Alle køn · Opdateret 16. sep. 2026 · NCT00001248RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
RekruttererFase 2
Alder 18 til 80 · Alle køn · Opdateret 15. sep. 2026 · NCT07002034Treatment of Cognitive Deficits in Multiple Sclerosis With High-Definition Transcranial Direct Current Stimulation
Rekrutterer
Alder 18 til 65 · Alle køn · Opdateret 15. sep. 2026 · NCT05958381Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis
RekruttererFase 3
Alder 18 til 60 · Alle køn · Opdateret 15. sep. 2026 · NCT07325292Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis
RekruttererFase 3
Alder 10 til 17 · Alle køn · Opdateret 10. sep. 2026 · NCT06408259A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 9. sep. 2026 · NCT06680037Exploring the Utility of [18F]3F4AP for Demyelination Imaging
RekruttererFase 1Frivillige med god helbredstilstand velkomne
Alder 18 til 90 · Alle køn · Opdateret 9. sep. 2026 · NCT06999434Natural History Study of Progressive Multifocal Leukoencephalopathy (PML)
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 2 til 120 · Alle køn · Opdateret 31. aug. 2026 · NCT01730131Evaluation of the Safety and Efficacy of a Full-Body Electrostimulation Garment for Individuals With Neurological and Neuromuscular Conditions That Cause Spasticity, Hyperreflexia, and Pain
Rekrutterer
Alder 18 til 75 · Alle køn · Opdateret 28. aug. 2026 · NCT07132775Identifying and Characterizing Preclinical MS
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 18 og opefter · Alle køn · Opdateret 27. aug. 2026 · NCT05787795Fra ClinicalTrials.gov, data hentet 4. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.